Jonathan Sessler

  • Professor
  • R. P. Doherty, Jr. - Welch Regents Chair in Chemistry
  • Chemistry
Profile image of Jonathan Sessler

Contact Information

Biography

Jonathan Sessler earned a B.S. in chemistry with highest honors from the University of California, Berkeley in 1977 and a Ph.D. in organic chemistry from Stanford University in 1982. Following postdoctoral fellowships with Jean-Marie Lehn at L'Université Louis Pasteur in France and research appointments in Kyoto, Japan, he joined the chemistry faculty in 1984. Sessler is internationally recognized for pioneering work in expanded porphyrins and their applications in biology and medicine. He is co-founder of Pharmacyclics, Inc., a biotechnology company acquired by AbbVie in 2015, and has authored more than 900 scientific publications and holds numerous U.S. patents.

Research

Research Areas

  • Vaccines and/or Therapeutics
  • Materials Science

Fields of Interest

  • Chemical Biology
  • Inorganic Chemistry
  • Inorganic Chemistry
  • Materials